Discover MSA Safety's Q4 2024 earnings insights, including strong margin growth, connected device innovations, and 2025 strategies amid dynamic ...

Evaxion Biotech (EVAX) has received confirmation from the Nasdaq Stock Market that it has re-established compliance with Nasdaq’s minimum stockholders’ equity requirement. Nasdaq has withdrawn ...

Lake Street analyst Thomas Flaten maintained a Buy rating on Evaxion Biotech (EVAX – Research Report) today and set a price target of $6.00. The company’s shares closed yesterday at $2.61.

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

BEIJING, Feb 14 (Reuters) - China issued guidelines on Friday to promote biotech cultivation, focusing on gene-editing tools and developing new wheat, corn, and soybean varieties, as part of ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved… accelant, a leader in sales, marketing, and revenue operations, is thrilled to announc ...

4D Molecular Therapeutics Inc. 3.39% $225.59M ...

Feb. 13, 2025 — A guardian molecule ensures that liver cells do not lose their identity. The discovery is of great interest for cancer medicine because a change of ...

After hours: February 18 at 6:56:49 PM EST Loading Chart for KRYS ...

Whether you are a recent graduate seeking a career change or a recipient of an advanced degree, there are ample job opportunities, including: Laboratory Technician Quality Assurance Clinical Research ...